ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

In Congress: Continuing Resolutions Keep Feds Running; Henney Nomination Stalled By Nickles

October 16, 1998

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976